SCAD Genetics: Why Your Heart Attack Risk Isn't Just About Cholesterol

What They Found

Swedish researchers sequenced the exomes of 201 patients with spontaneous coronary artery dissection (SCAD)—a condition where coronary arteries tear without trauma or intervention. They found rare genetic variants in previously identified SCAD-associated genes and discovered novel genetic alterations that may contribute to this poorly understood condition.

Why It Matters

SCAD is the great cardiovascular equalizer—it strikes young, healthy women with perfect lipid panels and no traditional risk factors. Unlike typical heart attacks driven by atherosclerotic plaque rupture, SCAD involves the arterial wall literally tearing apart, creating a false lumen that blocks blood flow.

This Swedish cohort of 201 patients represents serious statistical power for a rare condition. The fact that they're finding rare variants in known SCAD genes validates the genetic architecture we suspected, but the discovery of novel alterations is where this gets interesting. These aren't common polymorphisms—we're talking about rare, likely pathogenic variants that could explain why some people's arterial walls fail under stress while others withstand decades of hypertension.

The timing is crucial. SCAD often occurs during periods of intense physical or emotional stress, pregnancy, or hormonal fluctuations. The genetic variants likely create a substrate of weakness that becomes clinically relevant only when the perfect storm hits—think of it as having a structural defect that stays silent until the building shakes.

What I'd Watch For

This is a preprint, so peer review will be critical. The key limitation is that we need functional studies to prove these variants actually alter protein function. Finding a rare variant doesn't automatically mean it's causative—correlation isn't causation, even in genetics.

The next study needs to show how these genetic changes affect arterial wall integrity at the cellular level. Do they alter collagen synthesis? Compromise elastic fiber assembly? Affect smooth muscle cell function? Without mechanistic validation, we're just collecting interesting genetic curiosities.

Bottom Line

This reinforces that SCAD isn't just bad luck—there's genuine genetic predisposition at play. While we can't change genetics, understanding the pathways involved opens doors for targeted prevention strategies. No protocol changes yet, but this is building toward personalized cardiovascular risk assessment that goes far beyond traditional lipid panels.